The impact of cucurbita pepo oil on insomnia

Phase 2

• Conditions: Primary insomnia.; Primary insomnia; F51.01

• Registration Number: IRCT20180424039397N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 October 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

Age between 20 to 65 years
Individuals with sleep difficulty despite observance of sleep health tips
Those who have trouble starting sleep or those who are not satisfied with their sleep quality, or both.
Patients who score 3 or greater for either of the first two items on the Insomnia Severity Index
Patients whose total score of the first two items on the Insomnia Severity Index is 4 or greater, and whose main complaint is insomnia.

Exclusion Criteria

Having associated physical diseases such as cancer that cause insomnia
Having mental diseases such as psychosis
Having a history of drug abuse
Having neurological diseases such as the Parkinson's disease, Alzheimer's disease, and epilepsy
Pregnant and breast-feeding women
History of allergy to medicinal herbs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: Before intervention, one week after the study onset, after intervention is finished. Method of measurement: Sleep log form.;Subjective Quality of Sleep. Timepoint: Before intervention, one week after the study onset, after the intervention is finished. Method of measurement: Sleep log form.;Sleep efficiency. Timepoint: Before intervention, one week after the study onset, after the intervention is finished. Method of measurement: Sleep log form.;Delayed sleep initiation. Timepoint: Before intervention, one week after the study onset, after the intervention is finished. Method of measurement: Sleep log form.;Insomnia severity. Timepoint: Before intervention, one week after the study onset, after the intervention is finished. Method of measurement: Insomnia Severity Index.